Ramalho-Santos et al. (1) and Ivanova et
al. (2) , comparing the same three "stem cells"-embryonic stem cells (ESCs); neural stem cells (NSCs), referred to as neural progenitor/stem cells (NPCs) in the present study; and hematopoietic stem cells (HSCs)-with their differentiated counterparts, each identified a list of commonly expressed "stemness" genes, proposed to be important for conferring the functional characteristics of stem cells. The ability to capture expression profiles of cells using microarrays offers the possibility of defining a stem cell by its constellation of active genes. An intriguing question, however, is whether the functional commonalities (self-renewal and pluripotency) (3) among stem cells can be defined at the genetic level. Do all stem cells express a similar set of "stemness" genes necessary for their unique properties, or do different stem cells express different sets of genes that confer stemness?
We have independently carried out gene expression profiling of three types of stem or immature progenitor cells: ESCs, NPCs, and retinal progenitor/stem cells, or RPCs ( Fig. 1)  (4, 5) . The intersection of ESC-, NPC-and RPC-enriched genes defined a list of 385 genes that are collectively expressed by all three stem cells (6). It can be inferred that these genes may represent or include putative "stemness" genes. For the approach taken here to be able to define and support the notion of "stemness" genes, however, would also require that very similar sets of genes can be identified regardless of the type of stem cells used. To test the validity of this notion, we have collectively analyzed our results along with those from the studies of Ramalho-Santos et al. (1) and Ivanova et al. (2) (Figs. 2 and 3 ). To our surprise, a comparison of the three independently derived lists of "stemness" genes showed only one gene (integrin alpha-6) commonly identified in the three studies (Figs. 2A and 3A) (6). This finding raised serious concerns about the conclusions reported in (1) and (2), as was also critically highlighted by Burns and Zon (7).
We then examined whether the same extreme discrepancy was observed for the lists of genes expressed in one specific stem cell type. In marked contrast, there was a very significant overlap in the lists of stem cellspecific genes from the three studies. A total of 332 "ESC-enriched genes" (Fig. 2B ) (6) and 236 "NPC-enriched genes" (Fig. 2C ) (6) were identified by all three investigators. Statistical analysis (8) showed that these numbers are highly significant (P Ͻ 10 Ϫ8 ). These results strongly go against major differences in cells and analytical methodologies between groups as an explanation for the lack of overlap in the three lists of "stemness" genes. However, when we computed for "stemness" genes, based on genes commonly expressed in two types of stem cells, we found that the three studies overlap by only 10 genes, with P ϭ 1.4 ϫ 10 Ϫ4 (Fig. 2D) . Therefore, as the number of stem cell types intersected to identify "stemness" genes is increased, the overlap between datasets from different investigators drops dramatically.
To examine why that may be the case, we plotted a comparison of significance scores (Fig. 4) for the different categories of genes derived by each group [fold ). (D) Overlap of "stemness" genes-two types of stem cell (ESC/NPC)-enriched genes-is limited to 10 genes. The probability of this number of genes overlapping by chance is greatly increased. P Ͼ 10 Ϫ4 is not significant because there are more than 10 4 genes studied (8). (Fig. 4) . For example, we found that the log of the significance scores for individual ESC or NPC-specific transcripts are typically in the range of 6 to 10 over differentiated progenies in all three groups. Transcripts of "stemness" genes from intersection of two or more stem cells, from all three groups, commonly showed log significance scores in the 2 to 4 level. In contrast to ESC and NPC, for which each study came up with overlapping sets of genes that are uniquely or highly expressed exclusively in each stem cell type, none of the putative "stemness" genes in the three studies were highly expressed genes compared with differentiated cells. These results indicate that the expression of "stemness" genes common to all stem cells, if such genes exist at all, is only relatively elevated compared with differentiated cells. This would create a significant variation in the genes identified by differential expression, amplified by subtle differences in experimental conditions between different studies. We propose this as the most important basis for the extreme discrepancies in the lists of putative "stemness" genes.
TECHNICAL COMMENT
Our observation does not rule out the possibility that genes unique to all stem cells which are expressed at low levels may exist. However, it is clear that no one single study can confidently identify the bona fide genes that specify "stemness," and crossvalidation of lists generated independently by different investigators is crucial. For instance, the total of 24 genes commonly identified in two of the studies ( Figs. 2A  and 3A) is statistically significant and warrants further investigation (6). It is possible also that there are "stemness" genes that have not yet been identified and are not represented in the chips used. Genes that may be important for stem cell functions such as selfrenewal but that are also expressed in non-stem cells (for example, Stat3, gp130) are unlikely to be identified by a comparative microarray approach. Another possibility is that different stem cell types may use different gene networks to achieve selfrenewal or multipotency (10). Finally, "stemness" genes may only be transiently expressed, so that they are easily missed by comparing two homeostatic states. Further efforts to identify these genes will require different strategies.
In summary, speculations made from independent studies (1, 2) about identity of stemness genes do not hold up when the studies are compared. Our explanation for this also demonstrates the inherent problem of testing the stemness hypothesis using a profiling approach. lished methods on embryonic fibroblast feeder layer in the presence of leukemic inhibitory factor. NPCs were cultured as neurospheres derived from E12 embryos following an established protocol (11). Although the frequency of stem cells cannot be ascertained, this population consisted largely of cells that exhibit stem cell properties such as self-renewal and the capacity to generate the major cell types found in the central nervous system. RPCs were obtained from manually dissected from E14.5 mouse embryo retinas, a stage in which more than 90% of cells in the retina are undifferentiated neuroblasts (12). Mature retinas were dissected from day 10 postpartum (P10) mice. Lateral ventricular brain (LVbr) came from adult mice. Primary embryonic fibroblasts (PEF) were isolated from E13 embryo. All RNAs were extracted using Trizol. 5. Duplicate samples of total RNAs from stem/progenitor cells and differentiated cells were probed using the Affymetrix U74Av2 chip following established manufacturer's protocol. Samples that passed a priori quality control criteria were scaled using a 2% trimmed mean to perform comparative analyses. The high reproducibility of the samples for the replicate arrays was indicated by the high correlation coefficient values (between 0.95 and 0.98). An unsupervised-learning technique was applied by constructing an unweighted pair group method with arithmeticmean (UPGMA) tree using Pearson's correlation as the metric of similarity (13). This tree represented the inherent grouping in the sample set and the degree of closeness between samples. To find genes enriched in a given cell type, we followed the supervised-learning approach as described by Tusher et al.
. The statistical significance of the results was assessed using permutation testing. Genes that showed at most a 5% false discovery rate were reported as differentially expressed. Programs used in the analyses can be obtained through www. The P values arising from our Monte Carlo analysis are estimates of how unlikely it is that a degree of overlap in the gene lists of the different studies would arise by chance if the gene lists were chosen independently at random. The fact that P is small should be interpreted as suggesting that the processes through which these gene lists were generated have something in common (for example, if there was a small-to-moderate number of truly differentially expressed genes, these were very likely to be discovered in each of the studies, even if each of the studies also had a large number of false positives). In particular, the P values should not be interpreted as a measure of the confidence that all or even most of the overlapping genes are the correct ones." 9. ESC-and NPC-enriched genes were listed with their significance scores, as evaluated in the three studies by fold changes (FC) value or lower confidence bound (LCB) score, and tabulated for their log value. A graph is plotted as shown for the first 80 scores of ESC-and NPC-enriched genes (blue and orange curves in Fig.  4 ). To measure the extent to which the data implicate a gene as being differentially expressed in more than one stem cell type (for example, ESC and NPC), we took the average of the scores for differential expression between the two stem cells. A graph is plotted for ESC/NPC-enriched genes in each of the three studies (red curves in Fig. 4) . A similar approach was taken to get the curves for the ESC/NPC/RPC (this study) or ESC/NPC/HSC (other two studies) "stemness" genes for the intersection of three stem cells (green curves in Fig. 4 ). 
